Apologies if I sounded flippant. The first part of the article made it sound to me like companies weren’t developing this with any real urgency, hence why they had to do it themselves:

They knew that a fairly straightforward piece of software could make their lives much easier, but no companies were developing it quickly enough.

And I suppose what I meant by “basic medical care” is more that, at least to the extent I am aware of, the medical community is well-versed in how to manage the issue, and with the amount of people who suffer from T1 diabetes and the rapid rate of technological progression in society in general, these solutions should not only already be available but should be available to everyone, and shouldn’t be as expensive to manage as it is. Near the end of the article is the comment:

A team at the University of Otago in New Zealand has run a successful early-stage clinical trial of an open-source insulin pump. The goal is to provide free-of-charge design plans to qualified manufacturers to build pumps for a fraction of the cost of current commercial ones.

I suppose it just upsets me in general that the goal of building low cost insulin pumps isn’t a globally shared one across manufacturers.